Rusatom Healthcare, part of state nuclear corporation Rosatom, will build Russia’s first radiopharmaceutical plant to meet global GMP good manufacturing practice standards. The new production facility will be in Obninsk at the site of LYa Karpov Scientific Research Institute of Physics & Chemistry (NIFKhl) and will produce drugs for targeted cancer therapy. The design of pharmaceutical production will be carried out by the Central Design and Technological Institute. Pre-design work is planned to be completed this year, for commissioning in 2024  production in early 2025.

• Rosatom
• Russia
• Iodine-131
• Radiopharmaceutical
• Clinical trial
• Medication

Source: NEI Magazine

Date: Friday, 07 August 2020

Original article: neimagazine.com/news/newsrussia-to-open-radiopharmaceutical-plant-in-obninsk-8064702

Read more ...